OUR VISION is to be the world’s leader in nanosensor-based, point-of-care diagnostics for a wide variety of diseases including Covid-19, Traumatic Brain Injury (TBI), Sepsis and Stroke.

OUR VALUES include holding ourselves to the highest quality standards, driving to be the best in the industry, both individually and collectively, and having the highest levels of integrity and ethical behavior.



Sharad Joshi
President & CEO
Sharad Joshi is a global entrepreneurial medical devices CEO with a strong track record driving rapid global growth and laying the strategic foundations for sustained success through strategic and product innovation, proven sales/marketing and distribution channel building, and M&A/partnership/alliance leadership. He is a leader who fosters a mission-focused, fun and collaborative environment. Builds and leads makeovers of scalable management teams and organizations, while drawing future-critical next generation talent.Read More
James A. Wylie
Executive Chairman
Mr. Wylie is a proven business leader with 35 years of executive management experience in emerging and global businesses. He has held leadership positions as a general manager, division president, group executive and chief executive officer in both public and private sector companies including IMC, Albany International, Uniroyal, EcoScience and Diomed Holdings. Additionally, Mr. Wylie spent nine years providing strategic advisory and interim CEO services to institutional investors across a broad range of markets and technologies. His market and product line experience includes biotechnology, medical devices, diagnostics and medical service equipment, mobile wireless data communication, commodity and specialty chemicals, polymers, crop protection, and waste management equipment and services. Mr. Wylie has extensive experience in public and private financing, mergers and acquisitions, joint ventures, strategic alliances, state and federal regulatory affairs, legislative lobbying, media relations, and global operations. He has served on 9 Boards, stimulating change and driving corporate growth. Mr. Wylie holds a B.S. in Chemistry from Bates College and served on active duty as a Lieutenant in the US Navy Reserve. (Full Corporate and Executive management background available upon request.)Read More
Sergey Dryga
Ph.D., MBA
Chief Scientific Officer
Dr. Dryga joined BioDirection® in 2014 and has extensive experience in building cross-functional R&D teams and leading development of In Vitro Diagnostics, reagents and vaccines. Dr. Dryga is an experienced product-development leader with expertise in nano-biotechnology, molecular biology, protein engineering, system integration, and electrical and software engineering. Prior to joining BioDirection®, Dr. Dryga was VP of Immunochemistry at nanoMR, Inc., where he led the development of pathogen capture system for detection of sepsis. He held positions of increasing responsibility at SeraCare LifeSciences, Inc (Director, Virology/Immunology) and Alphavax, Inc. (Director of Analytical Research). Dr. Dryga is an inventor on 23 patents and over 30 patent applications; his work has been published in 16 peer-reviewed articles. Dr. Dryga has a Masters Degree in BioOrganic Chemistry (NSU, Russia), PhD in Molecular Biology (IMB, Russia) and MBA from Kenan-Flagler Business School (UNC). He completed post-doctoral training at Washington University in St. Louis in the lab of Prof. S. Schlesinger, where he studied replication of alphaviruses.Read More
Mike Sampson
Vice President of North American Sales
Mike Sampson is an accomplished global commercial leader with a successful 26-year track record in business development, strategic sales & commercial marketing management within the medical device and diagnostics point-of-care IVD industry. Mike has led teams across the globe establishing strategic partnerships to drive success within sales, marketing and information technology.  Leveraging his background in lab and point-of-care diagnostics, Mike has launched numerous GTM plans into new markets and rebuilt approaches to traditional markets to drive success into the future.  Across the last 12 years, Mike has focused his passion on POC as a true solution that improves the interaction and outcomes with the patient, while also delivering the ability to reduce the overall costs of healthcare.Read More

NanoDx is always searching for new opportunities. Contact us today with any questions or inquiries.

Contact Us